Investigating the potential of proton therapy for hypoxia-targeted dose escalation in non-small cell lung cancer

BACKGROUND: Hypoxia is known to be prevalent in solid tumors such as non-small cell lung cancer (NSCLC) and reportedly correlates with poor prognostic clinical outcome. PET imaging can provide in-vivo hypoxia measurements to support targeted radiotherapy treatment planning. We explore the potential...

Descripción completa

Detalles Bibliográficos
Autores principales: Köthe, Andreas, Bizzocchi, Nicola, Safai, Sairos, Lomax, Antony John, Weber, Damien Charles, Fattori, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507157/
https://www.ncbi.nlm.nih.gov/pubmed/34635135
http://dx.doi.org/10.1186/s13014-021-01914-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507157/
https://www.ncbi.nlm.nih.gov/pubmed/34635135
http://dx.doi.org/10.1186/s13014-021-01914-2

Ejemplares similares